Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)

Alzheimer’s Disease

Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease

J Alzheimers Dis.

Brugnolo A, De Carli F, Pagani M, Morbelli S, Jonsson C, Chincarini A, Frisoni GB, Galluzzi S, Perneczky R, Drzezga A, van Berckel BNM, Ossenkoppele R, Didic M, Guedj E, Arnaldi D, Massa F, Grazzini M, Pardini M, Mecocci P, Dottorini ME, Bauckneht M, Sambuceti G, Nobili F

doi: 10.3233/JAD-

Aging and Cognitive Functions

High performance plasma amyloid-β biomarkers for Alzheimer's disease

Nature

Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Doré V, Fowler C, Li QX, Martins R, Rowe C, Tomita T, Matsuzaki K, Ishii K, Ishii K, Arahata Y, Iwamoto S, Ito K, Tanaka K, Masters CL, Yanagisawa K

doi: 10.1038/nature25456.

Alzheimer’s Disease

Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury

J Alzheimers Dis.

DeCarli C, Villeneuve S, Maillard P, Harvey D, Singh B, Carmichael O, Fletcher E, Olichney J, Farias S, Jagust W, Reed B, Mungas D

doi: 10.3233/JAD-

Aging and Cognitive FunctionsAlzheimer’s DiseaseDementia

Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease

JAMA Neurol.

Quiroz YT, Sperling RA, Norton DJ, Baena A, Arboleda-Velasquez JF, Cosio D, Schultz A, Lapoint M, Guzman-Velez E, Miller JB, Kim LA, Chen K, Tariot PN, Lopera F, Reiman EM, Johnson KA

doi: 10.1001/jamaneurol.

Aging and Cognitive FunctionsAlzheimer’s Disease

Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease

JAMA Neurol.

Xia C, Makaretz SJ, Caso C, McGinnis S, Gomperts SN, Sepulcre J, Gomez-Isla T, Hyman BT, Schultz A, Vasdev N, Johnson KA, Dickerson BC

doi: 10.1001/

Alzheimer’s Disease

Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease

JAMA Neurol.

Yu L, Petyuk VA, Tasaki S, Boyle PA, Gaiteri C, Schneider JA, De Jager PL, Bennett DA

doi: 10.1001/jamaneurol.

Dementia

Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia

Alzheimers Dement.

Slot RER, Sikkes SAM, Berkhof J, Brodaty H, Buckley R, Cavedo E, Dardiotis E, Guillo-Benarous F, Hampel H, Kochan NA, Lista S, Luck T, Maruff P, Molinuevo JL, Kornhuber J, Reisberg B, Riedel-Heller SG, Risacher SL, Roehr S, Sachdev PS, Scarmeas N, Scheltens P, Shulman MB, Saykin AJ, Verfaillie SCJ, Visser PJ, Vos SJB, Wagner M, Wolfsgruber S, Jessen F; Alzheimer's Disease Neuroimaging Initiative, the DESCRIPA working group, the INSIGHT-preAD study group, on behalf of the SCD-I working group, van der Flier WM

doi: 10.1016/j.jalz.2018.10.003.

Dementia

Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET

Eur J Nucl Med Mol Imaging.

Brendel M, Schnabel J, Schönecker S, Wagner L, Brendel E, Meyer-Wilmes J, Unterrainer M, Schildan A, Patt M, Prix C, Ackl N, Catak C, Pogarell O, Levin J, Danek A, Buerger K, Bartenstein P, Barthel H, Sabri O, Rominger A

doi: 10.1007/

Aging and Cognitive FunctionsAlzheimer’s DiseaseDementia

Linking Amyloid-β and Tau Deposition in Alzheimer Disease

JAMA Neurol.

Vemuri P, Schöll M

doi: 10.1001/

Related content

Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease

High performance plasma amyloid-β biomarkers for Alzheimer's disease

Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury

Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease

Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease

Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease

Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia

Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET

Linking Amyloid-β and Tau Deposition in Alzheimer Disease